ครอบคลุมเทคโนโลยีที่สร้างความพลิกผัน (Disruptive Technology) และขับเคลื่อนธุรกิจในยุคดิจิทัล

Home > Archives > News > Bumrungrad International, the largest Private Hospital in South East Asia, Partners with BC Platforms
image
Bumrungrad International, the largest Private Hospital in South East Asia, Partners with BC Platforms
image
February 15, 2019 News

 

BC Platforms, a global leader in genomic data management and analytics today announced it is providing its world leading genomics platform, to Bumrungrad International, a multi-specialty hospital located in the heart of Bangkok, Thailand handling more than 1.1 million patients per year.

BC Platforms will be providing its customizable end-to-end Software-as-a-Service platform to enable Bumrungrad to offer personalized healthcare solutions for their patients in the clinic. The core system will be seamlessly integrated in the hospital infrastructure from laboratory to electronic patient record. Handling all types of genetic data from Genotype and NGS instruments to the clinical reporting needed to support the advanced patient care. Bumrungrad will also participate in providing its extensive Asian data and samples to BCRQUEST providing additional sample diversity and data resources for researchers. BCRQUEST is a global network of healthcare service providers and biobanks that provide genomic and clinical cohort data for pharmaceutical and medical research and development.

Artirat Charukitpipat, Chief Executive Officer at Bumrungrad, commented, “We are excited to be partnering with BC Platforms to bring personalized healthcare solutions into our clinical practice and research. We are looking forward to working with BC Platforms to set a new standard for predictive medicine complementing conventional treatment for our patients and clients across the globe.”

Tero Silvola, CEO of BC Platforms, said, “We are pleased that Bumrungrad has chosen to adopt our genomics platform for their clinical practice and to benefit research. We aim to build comprehensive collaboration programs with Bumrungrad to facilitate projects, where patients will benefit from the latest innovations and thereafter gain access to clinical trials relevant to their individual disease status. Bumrungrad is one of the largest healthcare providers in South East Asia and by contributing their data mainly focusing on Asian haplotypes to BCRQUEST we can greatly improve the diversity of our offering to research organizations worldwide.’

(0)(0)